Join us Feb. 5-7 in LA for the most anticipated clinical trial breakthroughs and discoveries of the year, including results for ESCAPE-MeVO, BEST, TRACE, MIND and many more.
Join us Feb. 5-7 in LA for the most anticipated clinical trial breakthroughs and discoveries of the year, including results for ESCAPE-MeVO, BEST, TRACE, MIND and many more.
Precision boosting, Ultra Ethernet, Reasoning Language Models, AI applications, and Supercomputing as driver for future societies!
🌠 Highly anticipated clinical trial results and analyses on breakthrough stroke treatments.
#ISC25#ISC25, Los Angeles
📅 Feb 5-7
🌠 Highly anticipated clinical trial results and analyses on breakthrough stroke treatments.
#ISC25#ISC25, Los Angeles
📅 Feb 5-7
Lightning talk submissions are due Feb 28, 2025.
Visit www.helmholtz-hirse.de/events/2025_... for further details!
#HPC #Supercomputing
Lightning talk submissions are due Feb 28, 2025.
Visit www.helmholtz-hirse.de/events/2025_... for further details!
#HPC #Supercomputing
@larofeticus.bsky.social
@larofeticus.bsky.social
www.cmu.edu/news/stories...
#HPC
www.cmu.edu/news/stories...
#HPC
@ahascience.bsky.social
#ISC25 opening session is in progress with program chair
@thoefler.bsky.social
#HPC #AI
#ISC25 opening session is in progress with program chair
@thoefler.bsky.social
#HPC #AI
@jimsieglermd.bsky.social
@jimsieglermd.bsky.social
There were no significant differences in outcomes among the three intervention groups in patients post-stroke.
There were no significant differences in outcomes among the three intervention groups in patients post-stroke.